- Kythera Biopharmaceuticals (NASDAQ:KYTH) prices its public offering of 2,604,168 shares of common stock at $48 per share. Underwriters over-allotment is an additional 390,625 shares. Closing date is March 16.
- Net proceeds will fund the ongoing development and commercialization of ATX-101, working capital and general corporate purposes.